List includes organizations in U.S., Belgium, China and Taiwan
Washington, D.C. - The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited nine more research organizations in the U.S., Belgium, China and Taiwan.
The newly accredited organizations include hospitals, academic institutions and integrated health care systems. They are:
“These accreditations are the latest indication that AAHRPP standards for research protections have become the international benchmark for high-quality, ethically sound human research-and that makes a difference for all of us,” AAHRPP President and CEO Elyse I. Summers said.
“Put another way, organizations that commit to AAHRPP accreditation are also committing to conduct top-tier ethical research, so we, in turn, can have confidence in the results and the advances they make possible.”
To date, 238 organizations have earned AAHRPP accreditation. Of these, 41 are located outside the United States. “More and more, organizations are recognizing that clinical research is a global enterprise, and protecting participants is a global responsibility,” Summers said.
To earn AAHRPP accreditation, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.
AAHRPP has accredited organizations in 47 states, Belgium, Brazil, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, South Africa, Taiwan and Thailand. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP
A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.